HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters

Some studies do not list a clear city. Always confirm the location with the study team.

Some visits may still be in person. Participation depends on the study’s location and eligibility requirements.

4317studies shown
Showing 73-84 of 4,317
Drug study icon
RecruitingNCT06926829

Long-term safety of EB-1020 after an earlier adult ADHD trial

About this title

A Long-term Trial of EB-1020 in Adult Patients With ADHD

Read the official source — NCT06926829
What is this study about?

Researchers are comparing EB-1020 (Centanafadine) 164.4 mg and EB-1020 (Centanafadine) 328.8 mg, tracking side effects to assess long-term safety in adults with ADHD.

In Tokyo
ADHDMedication studyAges 18–55
Countries
Japan
Sponsor
Otsuka Pharmaceutical Co., Ltd. (Pharmaceutical company)
Drug study icon
RecruitingNCT07087327

Long-term EB-1020 safety in children and adolescents with ADHD

About this title

A Long-term Trial of EB-1020 in Pediatric Patients With ADHD

Read the official source — NCT07087327
Official study title

A Phase 3, Multicenter, Open-label, Uncontrolled, Long-term Japan-China Joint Trial to Evaluate the Safety and Efficacy of EB-1020 QD XR Capsules Administered Orally Once Daily in Children and Adolescents With Attention- Deficit/Hyperactivity Disorder

In Sapporo
ADHDMedication studyAges 6–17
Countries
Japan
Sponsor
Otsuka Pharmaceutical Co., Ltd. (Pharmaceutical company)
Drug study icon
RecruitingNCT06820723

Brain effects of one CYB003 dose in depression with anxiety

About this title

A Mechanistic Study to Assess a Single Dose of CYB003 in Participants With Depression and Anxiety

Read the official source — NCT06820723
Official study title

A Randomized, Double-Blind, Placebo-Controlled Mechanistic Study to Assess a Single Oral Dose of CYB003 in Participants With Major Depressive Disorder (MDD) and Moderate to Severe Anxiety

In Columbus
Depression, AnxietyMedication studyAges 21–65
Countries
United States
Sponsor
Ohio State University
Behavioral study icon
RecruitingNCT06441786

Feasibility of group metacognitive therapy for autistic teenagers with anxiety or depression

About this title

A Metacognitive Group Therapy of Depression and Anxiety in Youth With Autism

Read the official source — NCT06441786
Official study title

A Metacognitive Group Therapy of Depression and Anxiety in Youth With Autism: Feasibility, Acceptability and Effect in a Clinical Open Trial

In Haninge
Anxiety, DepressionBehavioural studyAges 15–18
Countries
Sweden
Sponsor
Uppsala University
Behavioral study icon
RecruitingNCT05995678

STEP-Home workshop to support veterans’ return to civilian life and reduce suicide risk

About this title

A Mixed Methods Pilot Trial of the STEP Home Workshop to Improve Reintegration and Reduce Suicide Risk for Recently Transitioned Veterans

Read the official source — NCT05995678
Official study title

A Mixed Methods Pilot Trial of the STEP Home Workshop to Improve Reintegration and Reduce Suicide Risk for Recently Transitioned Veterans

In Boston
Suicidality, PTSDBehavioural studyAges 18–65
Countries
United States
Sponsor
VA Office of Research and Development (Government agency)
Other study type icon
RecruitingACTRN12613000844741

A mixed methods study of a family-based, parent-led intervention to improve resilience and wellbeing of families living with a childhood chronic illness.

Official study title

Improving the well-being and resilience of families of children and adolescents living with a chronic illness: an examination of the efficacy and acceptability of a stepped-care family resilience intervention, compared to standard mental helath promotion practices at one paediatric hospital in Australia.

In New Lambton
Mental healthInterventional studyAges 18–80
Countries
Australia
Sponsor
Hunter New England Local Health District / Hunter Institute of Mental Health

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.